UNSPSC 51281613: Framycetin
Commodity
Code facts
- Part of
-
-
51000000
-
51280000
- 51281600
-
51280000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51281613
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4BOC774388, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-beta-d-ribofuranosyl-(1-5))-2-deoxy- but generally known as framycetin, which bears US NIH Compound Identifier 8378.
Read the full definition
European Medicines Agency schedules Framycetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07814MIG. The term FRAMYCETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules framycetin in its Anatomical Therapeutic Chemical (ATC) Classification. FRAMYCETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule framycetin under HS 29419000 and SITC 54139.
As of Q4 2014, FRAMYCETIN remains the US FDA Preferred Term for this commodity. Framycetin bears US NLM identifiers UMLS ID C0016673 and NCI Concept Code C65770. SMILES: O(C1C(OC2OC(C(O)C(O)C2N)CN)C(N)CC(N)C1O)C1OC(C(OC2OC(C(O)C(O)C2N)CN)C1O)CO.
About UNSPSC 51281613
UNSPSC 51281613 Framycetin is a Commodity code representing pharmaceutical products that state and local health agencies procure through competitive bidding and cooperative purchasing agreements. Recent activity shows state and local governments buying pharmaceutical supplies—including antibiotics, opioid-reversal agents, and drug-deactivation systems—via piggyback contracts through regional pharmaceutical consortiums and direct IFB processes to support public health and emergency response missions.
The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for a 12-month initial term plus two renewal options, supplying Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets in bulk packages with specified expiration windows. Separately, Seminole County, Florida released an IFB in June 2026 (due July 26, 2023) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building; the contract carried a two-year initial term plus one-year renewal option, E-Verify compliance, standard insurance coverage requirements, and a three-month probationary termination clause. Recent activity centers on Florida and Illinois; the code shows limited visibility across other states in the source material. Health departments and county public health entities are the primary issuing bodies under this code, with procurement structured around cooperative purchasing vehicles (such as MMCAP Infuse) and traditional competitive bidding to manage pharmaceutical supply chains for both routine and emergency public health response needs.
Quick answers
What is UNSPSC 51281613?
UNSPSC 51281613 is Framycetin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51281613?
UNSPSC 51281613 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51281613
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code